BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22889411)

  • 1. Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase.
    Guo Z; Song E; Ma S; Wang X; Gao S; Shao C; Hu S; Jia L; Tian R; Xu T; Gao Y
    J Proteome Res; 2012 Oct; 11(10):4847-62. PubMed ID: 22889411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase.
    Lenihan JA; Saha O; Young PW
    PLoS One; 2017; 12(11):e0187352. PubMed ID: 29121065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evolution of the LNX gene family.
    Flynn M; Saha O; Young P
    BMC Evol Biol; 2011 Aug; 11():235. PubMed ID: 21827680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Molecular and Pathophysiological Functions of Members of the LNX/PDZRN E3 Ubiquitin Ligase Family.
    Hong J; Won M; Ro H
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33333989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of LNX1:Ubc13~Ubiquitin Complex Reveals the Role of Additional Motifs for the E3 Ligase Activity of LNX1.
    Nayak D; Sivaraman J
    J Mol Biol; 2018 Apr; 430(8):1173-1188. PubMed ID: 29496391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening E3 substrates using a live phage display library.
    Guo Z; Wang X; Li H; Gao Y
    PLoS One; 2013; 8(10):e76622. PubMed ID: 24124579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation.
    Nie J; McGill MA; Dermer M; Dho SE; Wolting CD; McGlade CJ
    EMBO J; 2002 Jan; 21(1-2):93-102. PubMed ID: 11782429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of RING-Between-RING E3 Ubiquitin Transfer Mechanisms.
    Reiter KH; Klevit RE
    Methods Mol Biol; 2018; 1844():3-17. PubMed ID: 30242699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
    Guharoy M; Bhowmick P; Tompa P
    J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligases.
    Ardley HC; Robinson PA
    Essays Biochem; 2005; 41():15-30. PubMed ID: 16250895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination screen using protein microarrays for comprehensive identification of Rsp5 substrates in yeast.
    Gupta R; Kus B; Fladd C; Wasmuth J; Tonikian R; Sidhu S; Krogan NJ; Parkinson J; Rotin D
    Mol Syst Biol; 2007; 3():116. PubMed ID: 17551511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a Wheat Cell-Free Synthesized Protein Array Containing 250 Human and Mouse E3 Ubiquitin Ligases to Identify Novel Interaction between E3 Ligases and Substrate Proteins.
    Takahashi H; Uematsu A; Yamanaka S; Imamura M; Nakajima T; Doi K; Yasuoka S; Takahashi C; Takeda H; Sawasaki T
    PLoS One; 2016; 11(6):e0156718. PubMed ID: 27249653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.
    Kar G; Keskin O; Nussinov R; Gursoy A
    J Proteome Res; 2012 Feb; 11(2):1196-207. PubMed ID: 22149024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Src is a PDZ interaction partner and substrate of the E3 ubiquitin ligase Ligand-of-Numb protein X1.
    Weiss A; Baumgartner M; Radziwill G; Dennler J; Moelling K
    FEBS Lett; 2007 Oct; 581(26):5131-6. PubMed ID: 17936276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A substrate-trapping strategy to find E3 ubiquitin ligase substrates identifies Parkin and TRIM28 targets.
    Watanabe M; Saeki Y; Takahashi H; Ohtake F; Yoshida Y; Kasuga Y; Kondo T; Yaguchi H; Suzuki M; Ishida H; Tanaka K; Hatakeyama S
    Commun Biol; 2020 Oct; 3(1):592. PubMed ID: 33082525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proteome arrays to globally identify substrates for E3 ubiquitin ligases.
    Persaud A; Rotin D
    Methods Mol Biol; 2011; 759():215-24. PubMed ID: 21863490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic interactions of proteins in complex networks: identifying the complete set of interacting E2s for functional investigation of E3-dependent protein ubiquitination.
    Christensen DE; Klevit RE
    FEBS J; 2009 Oct; 276(19):5381-9. PubMed ID: 19712108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
    Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X
    Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition.
    Uchiki T; Kim HT; Zhai B; Gygi SP; Johnston JA; O'Bryan JP; Goldberg AL
    J Biol Chem; 2009 May; 284(19):12622-32. PubMed ID: 19240029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Diversity of Ubiquitin E3 Ligase.
    Toma-Fukai S; Shimizu T
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.